Results 1 to 10 of about 70 (66)

Antimicrobial Resistance Symposium at ICEID 2000

open access: yesEmerging Infectious Diseases, 2001
Timothy Naimi   +3 more
doaj   +3 more sources

Emerging Infectious Diseases: A CDC Perspective [PDF]

open access: yesEmerging Infectious Diseases, 2001
James M. Hughes
doaj   +2 more sources

Emerging Viral Diseases of Southeast Asia and the Western Pacific

open access: yesEmerging Infectious Diseases, 2001
Over the past 6 years, a number of zoonotic and vectorborne viral diseases have emerged in Southeast Asia and the Western Pacific. Vectorborne disease agents discussed in this article include Japanese encephalitis, Barmah Forest, Ross River, and ...
J.S. Mackenzie   +20 more
doaj   +1 more source

Adaptation of Bordetella pertussis to Vaccination: A Cause for Its Reemergence?

open access: yesEmerging Infectious Diseases, 2001
In The Netherlands, as in many other western countries, pertussis vaccines have been used extensively for more than 40 years. Therefore, it is conceivable that vaccine-induced immunity has affected the evolution of B. pertussis.
Frits R. Mooi   +2 more
doaj   +1 more source

Antibacterial Household Products: Cause for Concern

open access: yesEmerging Infectious Diseases, 2001
The recent entry of products containing antibacterial agents into healthy households has escalated from a few dozen products in the mid-1990s to more than 700 today.
Stuart B. Levy
doaj   +1 more source

Epidemiology, Evolution, and Future of the HIV/AIDS Pandemic

open access: yesEmerging Infectious Diseases, 2001
We used mathematical models to address several questions concerning the epidemiologic and evolutionary future of HIV/AIDS in human populations. Our analysis suggests that 1) when HIV first enters a human population, and for many subsequent years, the ...
Bruce R. Levin   +2 more
doaj   +1 more source

Public/Private Sector Partnership For Emerging Infections

open access: yesEmerging Infectious Diseases, 2001
This paper gives examples of public/private partnerships that support research, support drug development and that advance policy development, suggesting that such partnerships can advance our understanding and control of emerging infections.
Enriqueta C. Bond
doaj   +1 more source

Home - About - Disclaimer - Privacy